Royal Bank of Canada’s Vivani Medical, Inc. Warrants expiring 03/14/2024 VANIW Stock Holding History

Royal Bank of Canada’s Portfolio VANIW Stock Details VANIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-47	Closed	–	–	7047
2017 Q3	$0	Hold	47	–	–	﹤0.01%	7101
2017 Q2	$0	Hold	47	–	–	﹤0.01%	6879
2017 Q1	$0	Buy	+47	New	+$147	﹤0.01%	6908

Other funds holding VANIW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

Royal Bank of Canada's VANIW Position: Q4 2017 in Review

Royal Bank of Canada sold out of Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) in Q4 2017, closing a stake of 47 shares.

Royal Bank of Canada first reported a position in VANIW in Q1 2017 and held it in 3 quarters. The position peaked at $0 in Q3 2017. 8 funds tracked by Wall St. Rank hold VANIW as of Q4 2017.

Royal Bank of Canada reported no remaining Vivani Medical, Inc. Warrants expiring 03/14/2024 position as of Q4 2017 after selling out during the quarter.
Royal Bank of Canada sold 47 Vivani Medical, Inc. Warrants expiring 03/14/2024 shares in Q4 2017.
Royal Bank of Canada first reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 in Q1 2017 and held it in 3 quarters.
Royal Bank of Canada's Vivani Medical, Inc. Warrants expiring 03/14/2024 position peaked at $0 in Q3 2017.
8 funds tracked by Wall St. Rank held Vivani Medical, Inc. Warrants expiring 03/14/2024 as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.